https://rutube.ru/video/3d5d057fc70427a86b8cdabbacc69d30/
1. Lusitropy - Wikipedia, https://en.wikipedia.org/wiki/Lusitropy
2. The Five -tropies of the Heart - FizzICU, https://www.fizzicu.com/the-five-tropies
3. The Five -tropies of the Heart - FizzICU, https://www.fizzicu.com/post/the-five-tropies-of-the-heart
4. Lusitropy – Knowledge and References - Taylor & Francis, https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Cardiology/Lusitropy/
5. Introduction to Tau (Diastolic Relaxation Time): Understanding the Science of Cardiac Relaxation - CD Leycom, https://www.cdleycom.com/introduction-to-tau-diastolic-relaxation-time-understanding-the-science-of-cardiac-relaxation/
6. Ionotrophy, chronotrophy, dromotrophy, lusirophy and bathmotrophy - Medicowesome, https://www.medicowesome.com/2016/06/ionotrophy-chronotrophy-dromotrophy.html
7. Physiology of the cardiovascular system, https://zona.fmed.uniba.sk/fileadmin/lf/sucasti/Teoreticke_ustavy/Fyziologicky_ustav/CVS_1_1819__Practical_.pdf
8. Cardiac Glycosides: Inotropic, Chronotropic, Dromotropic Drugs - Simple Nursing, https://simplenursing.com/inotropic-chronotropic-dromotropic-drugs/
9. Allosteric regulation of SERCA by phosphorylation-mediated ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC3808617/
10. Phospholamban pentamerization increases sensitivity and dynamic ..., https://academic.oup.com/cardiovascres/article/119/7/1568/7069261
11. Development of Small-molecule SERCA2a Stimulators: A Novel Class of Ino-lusitropic Agents - European Cardiology Review, https://www.ecrjournal.com/articles/development-small-molecule-serca2a-stimulators-novel-class-ino-lusitropic-agents?language_content_entity=en
12. SARCOLIPIN AND PHOSPHOLAMBAN AS REGULATORS OF CARDIAC SARCOPLASMIC RETICULUM CA2+ ATPASE - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC2743185/
13. Phospholamban: a major determinant of the cardiac force-frequency relationship, https://journals.physiology.org/doi/full/10.1152/ajpheart.2000.278.1.H249
14. Effects of Normobaric Hypoxia and Adrenergic Blockade over 72 h on Cardiac Function in Rats - MDPI, https://www.mdpi.com/1422-0067/24/14/11417
15. Ischemic Cardiac Dysfunction - Cardiovascular Physiology Concepts, https://cvphysiology.com/cad/cad011
16. Positive inotropic and negative lusitropic effects of endothelin receptor agonism in vivo, https://journals.physiology.org/doi/full/10.1152/ajpheart.00892.2004
17. Interpreting Diastolic Dynamics and Evaluation through Echocardiography - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC11433582/
18. Классификация хронической сердечной недостаточности: Типы и характеристики, https://www.teva.ru/just-about-health/articles/klassifikaciya-hsn/
19. Heart Failure With Preserved Ejection Fraction (HFpEF) - StatPearls - NCBI Bookshelf - NIH, https://www.ncbi.nlm.nih.gov/books/NBK599960/
20. Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction, https://www.ahajournals.org/doi/10.1161/circulationaha.114.013215
21. Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin | Request PDF - ResearchGate, https://www.researchgate.net/publication/271648114_Myocardial_Stiffness_in_Patients_With_Heart_Failure_and_a_Preserved_Ejection_Fraction_Contributions_of_Collagen_and_Titin
22. Increased myocardial stiffness more than impaired relaxation function limits cardiac performance during exercise in heart failure with preserved ejection fraction: a virtual patient study - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC9707905/
23. Time constant of isovolumic pressure decay (Tau) in patients stratified... - ResearchGate, https://www.researchgate.net/figure/Time-constant-of-isovolumic-pressure-decay-Tau-in-patients-stratified-according-to_fig2_279309300
24. Time Constants of Cardiac Function and Their Calculations - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC3002056/
25. Time Constants of Cardiac Function and Their Calculations, https://opencardiovascularmedicinejournal.com/VOLUME/4/PAGE/168/
26. Assessment of diastolic function by echocardiography – The Cardiovascular - ECGWaves, https://ecgwaves.com/topic/assessment-of-diastolic-function-by-echocardiography/
27. How to Measure and Grade Diastolic Dysfunction using Echocardiography - Diastology - POCUS 101, https://www.pocus101.com/how-to-measure-and-grade-diastolic-dysfunction-using-echocardiography/
28. Isovolumic relaxation time - Wikipedia, https://en.wikipedia.org/wiki/Isovolumic_relaxation_time
29. Specific Echo Parameters that Indicate Elevated LAP - Cardioserv, https://www.cardioserv.net/echo-elevated-lap/
30. Положительные инотропные средства для лечения острой сердечной недостаточности Текст научной статьи по специальности «Клиническая медицина - КиберЛенинка, https://cyberleninka.ru/article/n/polozhitelnye-inotropnye-sredstva-dlya-lecheniya-ostroy-serdechnoy-nedostatochnosti
31. ПОБОЧНЫЕ ДЕЙСТВИЯ ИНГИБИТОРОВ ФОСФОДИЭСТЕРАЗЫ (ФДЭ) Донецк 2021 ГОО В, https://old.dnmu.ru/wp-content/uploads/2021/02/18.-%D0%9F%D0%BE%D0%B1%D0%BE%D1%87%D0%BD%D1%8B%D0%B5-%D0%B4%D0%B5%D0%B9%D1%81%D1%82%D0%B2%D0%B8%D1%8F-%D0%B8%D0%BD%D0%B3%D0%B8%D0%B1%D0%B8%D1%82%D0%BE%D1%80%D0%BE%D0%B2-%D1%84%D0%BE%D1%81%D1%84%D0%BE%D0%B4%D0%B8%D1%8D%D1%81%D1%82%D0%B5%D1%80%D0%B0%D0%B7%D1%8B-%D0%A4%D0%94%D0%AD_%D0%9A%D1%80%D0%B8%D0%B2%D1%83%D1%89%D0%B5%D0%B2-%D0%92.%D0%91.pdf
32. Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies - Archives of Medical Science, https://www.archivesofmedicalscience.com/Levosimendan-in-the-modern-treatment-of-patients-with-acute-heart-failure-of-various,80898,0,2.html
33. Levosimendan in the treatment of patients with acute cardiac conditions - Via Medica Journals, https://journals.viamedica.pl/polish_heart_journal/article/download/82635/61970
34. Levosimendan - Deranged Physiology, https://derangedphysiology.com/main/cicm-primary-exam/cardiovascular-system/Chapter-978/levosimendan
35. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition - PMC - NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC3753840/
36. Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025 - FirstWord Pharma, https://firstwordpharma.com/story/5959916